Search Results - "Kitamei, Hirokuni"

Refine Results
  1. 1

    Prognostic factors of 2-year outcomes of ranibizumab therapy for polypoidal choroidal vasculopathy by Hikichi, Taiichi, Kitamei, Hirokuni, Shioya, Shoko

    Published in British journal of ophthalmology (01-06-2015)
    “…To determine predictors of 2-year outcomes after three, monthly, intravitreal ranibizumab (IVR) injections followed by as-needed injections for treatment-naive…”
    Get more information
    Journal Article
  2. 2

    Retinal pigment epithelial atrophy over polypoidal choroidal vasculopathy lesions during ranibizumab monotherapy by Hikichi, Taiichi, Kitamei, Hirokuni, Shioya, Shoko

    Published in BMC ophthalmology (16-05-2016)
    “…To evaluate the quantitative changes of retinal pigment epithelial (RPE) atrophy during 3-year follow-up period of ranibizumab monotherapy for polypoidal…”
    Get full text
    Journal Article
  3. 3

    Relation between changes in foveal choroidal thickness and 1-year results of ranibizumab therapy for polypoidal choroidal vasculopathy by Hikichi, Taiichi, Kitamei, Hirokuni, Shioya, Shoko, Higuchi, Makoto, Matsushita, Takuro, Kosaka, Shoko, Matsushita, Reiko, Takami, Kimitaka, Ohtsuka, Hideo

    Published in British journal of ophthalmology (01-09-2014)
    “…To determine a correlation between changes in the subfoveal choroidal thickness and outcomes 1 year after ranibizumab therapy for polypoidal choroidal…”
    Get more information
    Journal Article
  4. 4

    Clinical features of intraocular inflammation in Hokkaido, Japan by Kitamei, Hirokuni, Kitaichi, Nobuyoshi, Namba, Kenichi, Kotake, Satoshi, Goda, Chiho, Kitamura, Mizuki, Miyazaki, Akiko, Ohno, Shigeaki

    Published in Acta ophthalmologica (Oxford, England) (01-06-2009)
    “… Purpose:  We aimed to investigate the clinical features of intraocular inflammation/uveitis in Hokkaido, Japan. Methods:  We retrospectively reviewed the…”
    Get full text
    Journal Article
  5. 5

    Photodynamic therapy combined with intravitreal bevacizumab and sub-tenon triamcinolone acetonide injections for age-related macular degeneration by Yoshizawa, Chikako, Saito, Wataru, Hirose, Shigeki, Kitamei, Hirokuni, Noda, Kousuke, Ishida, Susumu

    Published in Japanese journal of ophthalmology (2013)
    “…Purpose To report the results of triple therapy with photodynamic therapy (PDT) (PDT combined with intravitreal injection of bevacizumab (IVB) and sub-tenon…”
    Get full text
    Journal Article
  6. 6

    Osteopontin Aggravates Experimental Autoimmune Uveoretinitis in Mice by Kitamura, Mizuki, Iwabuchi, Kazuya, Kitaichi, Nobuyoshi, Kon, Shigeyuki, Kitamei, Hirokuni, Namba, Kenichi, Yoshida, Kazuhiko, Denhardt, David T, Rittling, Susan R, Ohno, Shigeaki, Uede, Toshimitsu, Onoe, Kazunori

    Published in Journal of Immunology (15-05-2007)
    “…Human endogenous uveitis is a common sight-threatening intraocular inflammatory disease and has been studied extensively using a murine model of experimental…”
    Get full text
    Journal Article
  7. 7

    Comparative Study of Two Sets of Criteria for the Diagnosis of Vogt-Koyanagi-Harada’s Disease by Kitamura, Mizuki, Takami, Kimitaka, Kitachi, Nobuyoshi, Namba, Kenichi, Kitamei, Hirokuni, Kotake, Satoshi, Ohno, Shigeaki

    Published in American journal of ophthalmology (01-06-2005)
    “…The Vogt-Koyanagi-Harada’s (VKH) Disease Committee established the “Revised diagnostic criteria for VKH disease” in 2001. The purpose of the present study was…”
    Get full text
    Journal Article
  8. 8

    Amelioration of experimental autoimmune uveoretinitis (EAU) with an inhibitor of nuclear factor-κB (NF-κB), pyrrolidine dithiocarbamate by Kitamei, Hirokuni, Iwabuchi, Kazuya, Namba, Kenichi, Yoshida, Kazuhiko, Yanagawa, Yoshiki, Kitaichi, Nobuyoshi, Kitamura, Mizuki, Ohno, Shigeaki, Onoé, Kazunori

    Published in Journal of leukocyte biology (01-06-2006)
    “…Experimental autoimmune uveoretinitis (EAU) is a T helper type 1 cell‐mediated autoimmune disease, which serves as a model of human chronic uveitis. In this…”
    Get full text
    Journal Article
  9. 9

    The effects of Ginkgo biloba extract on lipopolysaccharide-induced inflammation in vitro and in vivo by Ilieva, Iliyana, Ohgami, Kazuhiro, Shiratori, Kenji, Koyama, Yoshikazu, Yoshida, Kazuhiko, Kase, Satoru, Kitamei, Hirokuni, Takemoto, Yuko, Yazawa, Kazunaga, Ohno, Shigeaki

    Published in Experimental eye research (01-08-2004)
    “…Purpose. Ginkgo biloba extract (GBE) contains many different flavone glycosides and terpenoides. Several previous studies have demonstrated that GBE exhibits a…”
    Get full text
    Journal Article
  10. 10

    Chickenpox Chorioretinitis with Retinal Exudates and Periphlebitis by Kitamei, Hirokuni, Namba, Kenichi, Kitaichi, Nobuyoshi, Wakayama, Akiko, Ohno, Shigeaki, Ishida, Susumu

    Published in Case reports in ophthalmology (01-05-2012)
    “…Background: Chickenpox is rarely associated with posterior segment inflammation. We report on a case of unilateral chickenpox chorioretinitis with retinal…”
    Get full text
    Journal Article
  11. 11

    Association of heat shock protein 70 induction and the amelioration of experimental autoimmune uveoretinitis in mice by Kitamei, Hirokuni, Kitaichi, Nobuyoshi, Yoshida, Kazuhiko, Nakai, Akira, Fujimoto, Mitsuaki, Kitamura, Mizuki, Iwabuchi, Kazuya, Miyazaki, Akiko, Namba, Kenichi, Ohno, Shigeaki, Onoé, Kazunori

    Published in Immunobiology (1979) (01-01-2007)
    “…Abstract Experimental autoimmune uveoretinitis (EAU) serves as a model of human endogeneous uveitis. In the present study we examined whether induction of heat…”
    Get full text
    Journal Article
  12. 12

    Efficacy and Safety of Intravitreal Aflibercept Treat-and-Extend Regimens in Exudative Age-Related Macular Degeneration: 52- and 96-Week Findings from ALTAIR: A Randomized Controlled Trial by Ohji, Masahito, Takahashi, Kanji, Okada, Annabelle A., Kobayashi, Masato, Matsuda, Yoshimi, Terano, Yasuhiro

    Published in Advances in therapy (01-03-2020)
    “…Purpose To evaluate efficacy and safety of intravitreal injections of aflibercept (IVT-AFL) treat-and-extend (T&E) dosing regimens in treatment-naïve patients…”
    Get full text
    Journal Article
  13. 13

    Results of 2 years of treatment with as-needed ranibizumab reinjection for polypoidal choroidal vasculopathy by Hikichi, Taiichi, Higuchi, Makoto, Matsushita, Takuro, Kosaka, Shoko, Matsushita, Reiko, Takami, Kimitaka, Ohtsuka, Hideo, Kitamei, Hirokuni, Shioya, Shoko

    Published in British journal of ophthalmology (01-05-2013)
    “…To investigate the 2-year outcomes of three monthly intravitreal ranibizumab injections followed by as-needed reinjections to treat polypoidal choroidal…”
    Get more information
    Journal Article
  14. 14

    Two-year outcomes of intravitreal bevacizumab therapy for macular oedema secondary to branch retinal vein occlusion by Hikichi, Taiichi, Higuchi, Makoto, Matsushita, Takuro, Kosaka, Shoko, Matsushita, Reiko, Takami, Kimitaka, Ohtsuka, Hideo, Kitamei, Hirokuni, Shioya, Shoko

    Published in British journal of ophthalmology (01-02-2014)
    “…To determine the 2-year outcomes of intravitreal bevacizumab (IVB) injections in eyes with macular oedema (ME) following branch retinal vein occlusion (BRVO)…”
    Get more information
    Journal Article
  15. 15

    Efficacy and Safety of Intravitreal Aflibercept Treat-and-Extend Regimens in the ALTAIR Study: 96-Week Outcomes in the Polypoidal Choroidal Vasculopathy Subgroup by Okada, Annabelle A., Takahashi, Kanji, Ohji, Masahito, Moon, SungChul Charles, Machewitz, Tobias, Sasaki, Koji

    Published in Advances in therapy (01-06-2022)
    “…Introduction To explore the efficacy and safety of intravitreal aflibercept (IVT-AFL) proactive, individualized treat-and-extend (T&E) regimens in exudative…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18

    Intraoperative endoscopic observation of sclerotomy site after cannula removal for 23-gauge vitrectomy by Hikichi, Taiichi, Kitamei, Hirokuni, Kosaka, Shoko, Shioya, Shoko, Takami, Kimitaka

    Published in Clinical ophthalmology (Auckland, N.Z.) (01-01-2014)
    “…The purpose of this study was to determine the incidence of vitreous incarceration in sclerotomy after cannula removal during 23-gauge vitrectomy. Thirty-seven…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Reply by Kitamura, Mizuki, Kitaichi, Nobuyoshi, Namba, Kenichi, Kitamei, Hirokuni, Ohno, Shigeaki

    Published in American journal of ophthalmology (01-04-2006)
    “…[...]big progress has been made in understanding this disease, as well as in examining patients, during the last three decades. [...]the First International…”
    Get full text
    Journal Article